Human Herpesvirus 6A and 6B transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis
OwnerGregory Bruce Wilson, R. Riley Shulerinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides transfer factors that confer cell-mediated immunity to Human Herpesvirus-6A and Human Herpesvirus-6B. The invention also provides pharmaceutical compositions comprising the transfer factors and methods of treating abnormalities in a subject using the transfer factors.
Claims29
A transfer factor effective to confer cell-mediated immunity wherein the immune response is to Human Herpesvirus-6A and Human Herpesvirus-6B.
A transfer factor effective to confer cell-mediated immunity wherein the immune response is to Human Herpesvirus-6A or Human Herpesvirus-6B
A method of treating Chronic Fatigue Syndrome in a subject, which comprises administering to the subject an amount of Human Herpesvirus-6A and Human Herpesvirus-6B transfer factors effective to treat the Chronic Fatigue Syndrome.
A method of treating Multiple Sclerosis in a subject, which comprises administering to the subject an amount of Human Herpesvirus-6 transfer factor effective to treat the Multiple Sclerosis.
A method of treating Multiple Sclerosis in a subject, which comprises administering to the subject an amount of Human Herpesvirus-6A and Human Herpesvirus-6B transfer factors effective to treat the Multiple Sclerosis.
Dependencies are inferred from the claim text.